McDermott Will & Emery Advises Poietis on its Partnership with L’Oréal - McDermott Will & Emery

McDermott Will & Emery Advises Poietis on its Partnership with L’Oréal

Overview


PARIS (22 November, 2016) — International law firm McDermott Will & Emery advised French biotechnology startup Poietis, a French leader for 3D bio printing, on its exclusive research partnership with L’Oréal to develop bio printing of hair.

Created in 2014 Poietis is a biotechnology company whose mission is to create and develop biological human tissues for research and regenerative medical purposes. The tissues are produced thanks to laser-assisted bio printing technology used to design, develop and manufacture biological tissues with microscopic precision and resolution. Winner of the 2014 ILab Contest (French National Competition for Innovative start-up Creation of the Ministry of Research, Creation-Development category) and the 2016 Worldwide Innovation Contest, Poietis is the only company to use this technology initially developed at the INSERM and Bordeaux University.

According to the companies’ representatives, this collaboration “should lead to the development of innovative applications in terms of tissue engineering.”

The McDermott team advising on the partnership was comprised of Paris based lawyers Anthony Paronneau and Anne-France Moreau.

McDermott’s Life Sciences Group works with clients to structure collaborative arrangements among emerging life sciences companies, established pharmaceutical and biotech companies and researchers and research institutions. These arrangements range from licensing technology to and from academic medical centers, universities and other research institutions, to complex strategic alliances among life sciences companies to achieve varied financial, research and development, manufacturing and distribution objectives. The Firm’s long-term experience in advising pharmaceuticals and agrochemical companies on taxation issues allows us to devise structures and tax plans for life sciences companies who wish to be attractive partners or acquisition candidates for the pharmaceutical industry.

About McDermott


McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,100 lawyers, we have offices in Boston, Brussels, Chicago, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.